PEA15 regulates the DNA damage-induced cell cycle checkpoint and oncogene-directed transformation

Molecular and Cellular Biology

Volumn 34, Issue 12, 2014, Pages 2264-2282

  Nagarajan, Arvindhan ^a   Dogra, Shaillay Kumar ^b   Liu, Alex Y ^a   Green, Michael R ^c   Wajapeyee, Narendra ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AGENCY FOR SCIENCE   (Singapore)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN B; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 6; PEPTIDES AND PROTEINS; PROTEIN C JUN; PROTEIN ENRICHED IN ASTROCYTE 15; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CELL CYCLE CHECKPOINT; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL TRANSFORMATION; COLON CANCER; DNA DAMAGE CHECKPOINT; DOWN REGULATION; HUMAN; LUNG CANCER; MUTAGENESIS; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; REGULATORY MECHANISM;

AMINO ACID SEQUENCE; ANIMALS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; CDC25 PHOSPHATASES; CELL CYCLE CHECKPOINTS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE 6; DNA DAMAGE; DNA METHYLATION; EPIGENESIS, GENETIC; G2 PHASE CELL CYCLE CHECKPOINTS; GENE SILENCING; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MOLECULAR SEQUENCE DATA; ONCOGENES; PEPTIDE HYDROLASES; PHOSPHOPROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STABILITY; PROTEOLYSIS; RAS PROTEINS; TWO-HYBRID SYSTEM TECHNIQUES; UBIQUITINATION;

EID: 84901312171     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01542-13     Document Type: Article

References (50)

1. Lowe SW, Cepero E, Evan G. 2004. Intrinsic tumour suppression. Nature 432:307-315. http://dx.doi.org/10.1038/nature03098.
2. Yaswen P, Campisi J. 2007. Oncogene-induced senescence pathways weave an intricate tapestry. Cell 128:233-234. http://dx.doi.org/10.1016/j.cell.2007.01.005.
3. Rodier F, Campisi J. 2011. Four faces of cellular senescence. J. Cell Biol. 192:547-556. http://dx.doi.org/10.1083/jcb.201009094.
4. Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C, Schurra C, Garre M, Nuciforo PG, Bensimon A, Maestro R, Pelicci PG, d'Adda di Fagagna F. 2006. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444:638-642 http://dx.doi.org/10.1038/nature05327.
5. Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, Vassiliou LV, Kolettas E, Niforou K, Zoumpourlis VC, Takaoka M, Nakagawa H, Tort F, Fugger K, Johansson F, Sehested M, Andersen CL, Dyrskjot L, Orntoft T, Lukas J, Kittas C, Helleday T, Halazonetis TD, Bartek J, Gorgoulis VG. 2006. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444:633-637. http://dx.doi.org/10.1038/nature05268.
6. Lujambio A, Akkari L, Simon J, Grace D, Tschaharganeh DF, Bolden JE, Zhao Z, Thapar V, Joyce JA, Krizhanovsky V, Lowe SW. 2013. Non-cell-autonomous tumor suppression by p53. Cell 153:449-460. http://dx.doi.org/10.1016/j.cell.2013.03.020.
7. 2 arrest after DNA damage. Science 282:1497-1501. http://dx.doi.org/10.1126/science.282.5393.1497.
8. Morgan SE, Kastan MB. 1997. p53 and ATM: cell cycle, cell death, and cancer. Adv. Cancer Res. 71:1-25. http://dx.doi.org/10.1016/S0065-230X(08)60095-0.
9. Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR. 2008. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 132:363-374. http://dx.doi.org/10.1016/j.cell.2007.12.032.
10. Fiory F, Formisano P, Perruolo G, Beguinot F. 2009. Frontiers: PED/ PEA-15, a multifunctional protein controlling cell survival and glucose metabolism. Am. J. Physiol. Endocrinol. Metab. 297:E592-E601. http://dx.doi.org/10.1152/ajpendo.00228.2009.
11. Formstecher E, Ramos JW, Fauquet M, Calderwood DA, Hsieh JC, Canton B, Nguyen XT, Barnier JV, Camonis J, Ginsberg MH, Chneiweiss H. 2001. PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. Dev. Cell 1:239-250. http://dx.doi.org/10.1016/S1534-5807(01)00035-1.
12. Schmittgen TD, Livak KJ. 2008. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3:1101-1108. http://dx.doi.org/10.1038/nprot.2008.73.
13. Raha T, Cheng SW, Green MR. 2005. HIV-1 Tat stimulates transcription complex assembly through recruitment of TBP in the absence of TAFs. PLoS Biol. 3:e44. http://dx.doi.org/10.1371/journal.pbio.0030044.
14. Santra MK, Wajapeyee N, Green MR. 2009. F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage. Nature 459:722-725. http://dx.doi.org/10.1038/nature08011.
15. Whitfield ML, Sherlock G, Saldanha AJ, Murray JI, Ball CA, Alexander KE, Matese JC, Perou CM, Hurt MM, Brown PO, Botstein D. 2002. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol. Biol. Cell 13:1977-2000. http://dx.doi.org/10.1091/mbc.02-02-0030..
16. Hurov KE, Cotta-Ramusino C, Elledge SJ. 2010. A genetic screen identifies the Triple T complex required for DNA damage signaling and ATM and ATR stability. Genes Dev. 24:1939-1950. http://dx.doi.org/10.1101/gad.1934210.
17. Fang M, Xia F, Mahalingam M, Virbasius CM, Wajapeyee N, Green MR. 2013. MEN1 is a melanoma tumor suppressor that preserves genomic integrity by stimulating transcription of genes that promote homologous recombination-directed DNA repair. Mol. Cell. Biol. 33:2635- 2647. http://dx.doi.org/10.1128/MCB.00167-13.
18. Shan J, Zhao W, Gu W. 2009. Suppression of cancer cell growth by promoting cyclin D1 degradation. Mol. Cell 36:469-476. http://dx.doi.org/10.1016/j.molcel.2009.10.018.
19. MacLachlan TK, Somasundaram K, Sgagias M, Shifman Y, Muschel RJ, Cowan KH, El-Deiry WS. 2000. BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expression. J. Biol. Chem. 275:2777-2785. http://dx.doi.org/10.1074/jbc.275.4.2777.
20. Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB, Siliciano JD. 1998. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281:1677- 1679. http://dx.doi.org/10.1126/science.281.5383.1677.
21. Du P, Kibbe WA, Lin SM. 2008. lumi: a pipeline for processing Illumina microarray. Bioinformatics 24:1547-1548. http://dx.doi.org/10.1093/bioinformatics/btn224.
22. Smyth GK. 2004. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3:Article3. http://dx.doi.org/10.2202/1544-6115.1027.
23. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B Stat. Methodol. 57:289-300.
24. Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, Lam WL, Schubeler D. 2005. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat. Genet. 37:853-862. http://dx.doi.org/10.1038/ng1598.
25. Shieh SY, Ikeda M, Taya Y, Prives C. 1997. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91:325-334. http://dx.doi.org/10.1016/S0092-8674(00)80416-X.
26. Wei N, Deng XW. 2003. The COP9 signalosome. Annu. Rev. Cell Dev. Biol. 19:261-286. http://dx.doi.org/10.1146/annurev.cellbio.19.111301.112449.
27. Liu Y, Shah SV, Xiang X, Wang J, Deng ZB, Liu C, Zhang L, Wu J, Edmonds T, Jambor C, Kappes JC, Zhang HG. 2009. COP9-associated CSN5 regulates exosomal protein deubiquitination and sorting. Am. J. Pathol. 174:1415-1425. http://dx.doi.org/10.2353/ajpath.2009.080861.
28. Chamovitz DA, Segal D. 2001. JAB1/CSN5 and the COP9 signalosome. A complex situation. EMBO Rep. 2:96-101. http://dx.doi.org/10.1093/embo-reports/kve028.
29. Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER, 3rd, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini N, Lerenthal Y, Shiloh Y, Gygi SP, Elledge SJ. 2007. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316:1160- 1166. http://dx.doi.org/10.1126/science.1140321.
30. Bemis L, Chan DA, Finkielstein CV, Qi L, Sutphin PD, Chen X, Stenmark K, Giaccia AJ, Zundel W. 2004. Distinct aerobic and hypoxic mechanisms of HIF-alpha regulation by CSN5. Genes Dev. 18:739-744. http://dx.doi.org/10.1101/gad.1180104.
31. Cope GA, Deshaies RJ. 2003. COP9 signalosome: a multifunctional regulator of SCF and other cullin-based ubiquitin ligases. Cell 114:663-671. http://dx.doi.org/10.1016/S0092-8674(03)00722-0.
32. Wei N, Serino G, Deng XW. 2008. The COP9 signalosome: more than a protease. Trends Biochem. Sci. 33:592-600. http://dx.doi.org/10.1016/j.tibs.2008.09.004.
33. Wolf DA, Zhou C, Wee S. 2003. The COP9 signalosome: an assembly and maintenance platform for cullin ubiquitin ligases? Nat. Cell Biol. 5:1029- 1033. http://dx.doi.org/10.1038/ncb1203-1029.
34. Lyapina S, Cope G, Shevchenko A, Serino G, Tsuge T, Zhou C, Wolf DA, Wei N, Deshaies RJ. 2001. Promotion of NEDD-CUL1 conjugate cleavage by COP9 signalosome. Science 292:1382-1385. http://dx.doi.org/10.1126/science.1059780.
35. Zhou BB, Elledge SJ. 2000. The DNA damage response: putting checkpoints in perspective. Nature 408:433-439. http://dx.doi.org/10.1038/35044005.
36. 2/M transition. Cell 128:1119-1132. http://dx.doi.org/10.1016/j.cell.2006.11.053.
37. Strausfeld U, Labbe JC, Fesquet D, Cavadore JC, Picard A, Sadhu K, Russell P, Doree M. 1991. Dephosphorylation and activation of a p34cdc2/cyclin B complex in vitro by human CDC25 protein. Nature 351:242-245. http://dx.doi.org/10.1038/351242a0.
38. Boutros R, Lobjois V, Ducommun B. 2007. CDC25 phosphatases in cancer cells: key players? Good targets? Nat. Rev. Cancer 7:495-507. http://dx.doi.org/10.1038/nrc2169.
39. Leppa S, Saffrich R, Ansorge W, Bohmann D. 1998. Differential regulation of c-Jun by ERK and JNK during PC12 cell differentiation. EMBO J. 17:4404-4413. http://dx.doi.org/10.1093/emboj/17.15.4404.
40. Hamad NM, Elconin JH, Karnoub AE, Bai W, Rich JN, Abraham RT, Der CJ, Counter CM. 2002. Distinct requirements for Ras oncogenesis in human versus mouse cells. Genes Dev. 16:2045-2057. http://dx.doi.org/10.1101/gad.993902.
41. Harper JW, Elledge SJ. 2007. The DNA damage response: ten years after. Mol. Cell 28:739-745. http://dx.doi.org/10.1016/j.molcel.2007.11.015.
42. Ciccia A, Elledge SJ. 2010. The DNA damage response: making it safe to play with knives. Mol. Cell 40:179-204. http://dx.doi.org/10.1016/j.molcel.2010.09.019.
43. Campisi J. 2001. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 11:S27-S31. http://dx.doi.org/10.1016/S0962-8924(01)82148-6.
44. Malumbres M, Perez De Castro I, Hernandez MI, Jimenez M, Corral T, Pellicer A. 2000. Cellular response to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15INK4b. Mol. Cell. Biol. 20:2915-2925. http://dx.doi.org/10.1128/MCB.20.8.2915-2925.2000.
45. Sulzmaier FJ, Valmiki MK, Nelson DA, Caliva MJ, Geerts D, Matter ML, White EP, Ramos JW. 2012. PEA-15 potentiates H-Ras-mediated epithelial cell transformation through phospholipase D. Oncogene 31: 3547-3560. http://dx.doi.org/10.1038/onc.2011.514.
46. Glading A, Koziol JA, Krueger J, Ginsberg MH. 2007. PEA-15 inhibits tumor cell invasion by binding to extracellular signal-regulated kinase 1/2. Cancer Res. 67:1536-1544. http://dx.doi.org/10.1158/0008-5472.CAN-06-1378.
47. Bartholomeusz C, Gonzalez-Angulo AM, Kazansky A, Krishnamurthy S, Liu P, Yuan LX, Yamasaki F, Liu S, Hayashi N, Zhang D, Esteva FJ, Hortobagyi GN, Ueno NT. 2010. PEA-15 inhibits tumorigenesis in an MDA-MB-468 triple-negative breast cancer xenograft model through increased cytoplasmic localization of activated extracellular signal-regulated kinase. Clin. Cancer Res. 16:1802-1811. http://dx.doi.org/10.1158/1078-0432.CCR-09-1456.
48. Bartholomeusz C, Rosen D, Wei C, Kazansky A, Yamasaki F, Takahashi T, Itamochi H, Kondo S, Liu J, Ueno NT. 2008. PEA-15 induces autophagy in human ovarian cancer cells and is associated with prolonged overall survival. Cancer Res. 68:9302-9310. http://dx.doi.org/10.1158/0008-5472.CAN-08-2592.
49. Rangarajan A, Hong SJ, Gifford A, Weinberg RA. 2004. Species- and cell type-specific requirements for cellular transformation. Cancer Cell 6:171-183 http://dx.doi.org/10.1016/j.ccr.2004.07.009.
50. Gaumont-Leclerc MF, Mukhopadhyay UK, Goumard S, Ferbeyre G. 2004. PEA-15 is inhibited by adenovirus E1A and plays a role in ERK nuclear export and Ras-induced senescence. J. Biol. Chem. 279:46802- 46809. http://dx.doi.org/10.1074/jbc.M403893200.